Acute Ischemic Stroke Intervention

Priyank Khandelwal, Dileep R Yavagal, Ralph L Sacco

Research output: Contribution to journalReview article

36 Citations (Scopus)

Abstract

Acute ischemic stroke (AIS) is the leading cause of disability worldwide and among the leading causes of mortality. Although intravenous tissue plasminogen activator (IV-rtPA) was approved nearly 2 decades ago for treatment of AIS, only a minority of patients receive it due to a narrow time window for administration and several contraindications to its use. Endovascular approaches to recanalization in AIS developed in the 1980s, and recently, 5 major randomized trials showed an overwhelming superior benefit of combining endovascular mechanical thrombectomy with IV-rtPA over IV-rtPA alone. In this paper, we discuss the evolution of catheter-based treatment from first-generation thrombectomy devices to the game-changing stent retrievers, results from recent trials, and the evolving stroke systems of care to provide timely access to acute stroke intervention to patients in the United States.

Original languageEnglish (US)
Pages (from-to)2631-2644
Number of pages14
JournalJournal of the American College of Cardiology
Volume67
Issue number22
DOIs
StatePublished - Jun 7 2016

Fingerprint

Stroke
Thrombectomy
Tissue Plasminogen Activator
Stents
Catheters
Equipment and Supplies
Mortality
Therapeutics

Keywords

  • large vessel occlusion
  • mechanical thrombectomy
  • stent retrievers
  • stroke systems

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Acute Ischemic Stroke Intervention. / Khandelwal, Priyank; Yavagal, Dileep R; Sacco, Ralph L.

In: Journal of the American College of Cardiology, Vol. 67, No. 22, 07.06.2016, p. 2631-2644.

Research output: Contribution to journalReview article

@article{c4ad4ff75faa430696ca203b6a0059d5,
title = "Acute Ischemic Stroke Intervention",
abstract = "Acute ischemic stroke (AIS) is the leading cause of disability worldwide and among the leading causes of mortality. Although intravenous tissue plasminogen activator (IV-rtPA) was approved nearly 2 decades ago for treatment of AIS, only a minority of patients receive it due to a narrow time window for administration and several contraindications to its use. Endovascular approaches to recanalization in AIS developed in the 1980s, and recently, 5 major randomized trials showed an overwhelming superior benefit of combining endovascular mechanical thrombectomy with IV-rtPA over IV-rtPA alone. In this paper, we discuss the evolution of catheter-based treatment from first-generation thrombectomy devices to the game-changing stent retrievers, results from recent trials, and the evolving stroke systems of care to provide timely access to acute stroke intervention to patients in the United States.",
keywords = "large vessel occlusion, mechanical thrombectomy, stent retrievers, stroke systems",
author = "Priyank Khandelwal and Yavagal, {Dileep R} and Sacco, {Ralph L}",
year = "2016",
month = "6",
day = "7",
doi = "10.1016/j.jacc.2016.03.555",
language = "English (US)",
volume = "67",
pages = "2631--2644",
journal = "Journal of the American College of Cardiology",
issn = "0735-1097",
publisher = "Elsevier USA",
number = "22",

}

TY - JOUR

T1 - Acute Ischemic Stroke Intervention

AU - Khandelwal, Priyank

AU - Yavagal, Dileep R

AU - Sacco, Ralph L

PY - 2016/6/7

Y1 - 2016/6/7

N2 - Acute ischemic stroke (AIS) is the leading cause of disability worldwide and among the leading causes of mortality. Although intravenous tissue plasminogen activator (IV-rtPA) was approved nearly 2 decades ago for treatment of AIS, only a minority of patients receive it due to a narrow time window for administration and several contraindications to its use. Endovascular approaches to recanalization in AIS developed in the 1980s, and recently, 5 major randomized trials showed an overwhelming superior benefit of combining endovascular mechanical thrombectomy with IV-rtPA over IV-rtPA alone. In this paper, we discuss the evolution of catheter-based treatment from first-generation thrombectomy devices to the game-changing stent retrievers, results from recent trials, and the evolving stroke systems of care to provide timely access to acute stroke intervention to patients in the United States.

AB - Acute ischemic stroke (AIS) is the leading cause of disability worldwide and among the leading causes of mortality. Although intravenous tissue plasminogen activator (IV-rtPA) was approved nearly 2 decades ago for treatment of AIS, only a minority of patients receive it due to a narrow time window for administration and several contraindications to its use. Endovascular approaches to recanalization in AIS developed in the 1980s, and recently, 5 major randomized trials showed an overwhelming superior benefit of combining endovascular mechanical thrombectomy with IV-rtPA over IV-rtPA alone. In this paper, we discuss the evolution of catheter-based treatment from first-generation thrombectomy devices to the game-changing stent retrievers, results from recent trials, and the evolving stroke systems of care to provide timely access to acute stroke intervention to patients in the United States.

KW - large vessel occlusion

KW - mechanical thrombectomy

KW - stent retrievers

KW - stroke systems

UR - http://www.scopus.com/inward/record.url?scp=84977606075&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84977606075&partnerID=8YFLogxK

U2 - 10.1016/j.jacc.2016.03.555

DO - 10.1016/j.jacc.2016.03.555

M3 - Review article

VL - 67

SP - 2631

EP - 2644

JO - Journal of the American College of Cardiology

JF - Journal of the American College of Cardiology

SN - 0735-1097

IS - 22

ER -